Find out if you’re eligible for Microdose GLP-1Rx
What is your weight loss goal?
Microdose: The Easy Way to Start a GLP-1
Noom Microdose GLP‑1Rx Program helps you lose weight and get healthy.
- Affordable – plans start at $991
- Friendly – designed to minimize side effects
- Paired with behavior change and coaching – for results that last
Why Noom Microdose?
Plans start at just $991
Affordable care that provides real results, including meds, clinical visits, and ongoing support
Lose up to 17 pounds in 60 days2
Lose weight comfortably with dosing tailored to your body and pace.
Behavior change and coaching
Get access to Noom GLP-1 Companion for extra support
Whole‑health wins
Optimize your biomarkers, health, and vitality while losing weight
How it Works
-
1
Take a brief intake survey
Share your health history and weight-loss goals and receive your clinical plan.
-
2
Connect with an expert clinician
A clinician will quickly evaluate your results and provide a prescription all online, if clinically appropriate.
-
3
Start losing weight with your customized Microdose plan
Get medication shipped, if eligible, and begin your journey with the lowest effective dose that delivers results.3
-
4
Ongoing care and medication
Receive continuous monitoring and adjustments, with unlimited access to your clinician and medication refills, where clinically appropriate.
Success Stories
“My medication has removed my cravings for sugar. I am down 16 pounds.”
“Noom provided me with the medication which I could not get through Medicare. I have learned the tricks to better eating and life in general."
Read More About GLP-1s
Frequently Asked Questions
1 Initial 3-week subscription and 4 weeks of medication from $99 plus tax and $199 per month plus tax for 12-week subscription thereafter.
2 Weight loss represents the top 25th percentile of self-reported data from 1,185 Noom Med users prescribed compounded GLP-1s. Average weight loss was 13 pounds.
3 Not all medications are available for home delivery. Availability of home delivery will depend on your insurance or cash pay status. If your clinician feels compounded medications are clinically appropriate for you, any compounded medications are not approved by the FDA or reviewed for quality, safety or efficacy. Novo Nordisk, Inc. is the only United States company with FDA-approved products containing semaglutide, identified under the trade names Rybelsus®, Ozempic® and Wegovy®. Lilly USA LLC is the only United States company with FDA-approved products containing tirzepatide identified under the trade names Zepbound® and Mounjaro®
